Quite the controversial figure at present, Novak Djokovic owns 80% stake in a Biotech firm QuantBioRes working on the cure for COVID. Centered in Copenhagen, the company is working on a peptide therapy for Covid-19 that will prevent the virus from infecting human cells.
- EXPLOSIVE: Here’s what was uncovered in Hunter Biden’s iCloud Hack
- MAJOR PEER REVIEWED STUDY: Moderna Vaccine Increases Myocarditis Risk By 44 Times In Young Adults
- MUST READ: High Level International Bankers Simulate The Collapse Of Global Financial System
- BIG STORY: Wuhan Lab Isolated Monkeypox Strain In 2020
- EXPLOSIVE: Ukraine Biolabs Used Fever Carrying Mosquitoes To Spark Dengue Pandemic In Cuba
Novak Djokovic, the men’s tennis champion, has returned to Belgrade with his family after being deported from Australia last week.
Djokovic and his wife own an 80 percent ownership in Danish biotech firm QuantBioRes, which is focusing on creating a cure for SARS-CoV-2, according to Reuters. Djokovic and his wife have unwittingly (or not) become the focal point of the international discussion around mandatory vaccines.
Ivan Loncarevic, the CEO of QuantBioRes, has characterized himself as an entrepreneur, claiming that Djokovic bought an 80 percent ownership in the company in June 2020, but declining to specify how much he paid for it.
According to the company, it employs roughly a dozen researchers in Denmark, Australia, and Slovenia. Djokovic and his wife Jelena own 40.8 percent and 39.2 percent of QuantBioRes, respectively, according to the Danish corporate registry.
Subscribe to GreatGameIndia
QuantBioRes, centered in Copenhagen, is working on a peptide therapy for Covid-19 that will prevent the virus from infecting human cells. The company plans to begin clinical studies in the United Kingdom later this year, and it now has a dozen scientists operating in Denmark, Australia, and Slovenia, according to Loncarevic.
Djokovic has had tremendous success; Forbes named him one of the top 50 highest-paid athletes in the planet for 2021, with on-court earnings of $4.5MM. That figure was overshadowed by the $30 million he allegedly made off the court. His total profits are estimated to be approximately €150MM ($170MM).
The peptide therapy, according to Loncarevic, is a medicinal treatment for COVID, not a vaccination.
But, as he approaches his 30th birthday, Djokovic’s pursuit to overcome his tie with Swiss icon Roger Federer as the world’s best (male) tennis player is running out of time.
Djoko must have hoped to win the Australian Open, that could have given him his 21st grand slam championship and end his tie with Roger Federer for the highest “grand slam” wins achieved by an individual (male) player.
Djoko’s main worry beyond February is the next grand slam competition, the French Open, which takes place in May.
Regrettably, the French sports ministry has already stated that no exemptions to the new vaccine rule will be granted.